Autoimmune hepatitis in the hiv-infected patient: A therapeutic dilemma

AIDS Patient Care and STDs

Volumn 23, Issue 6, 2009, Pages 407-413

  Wan, David W ^a   Marks, Kristen ^b   Yantiss, Rhonda K ^b   Talal, Andrew H ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Department of Molecular Biology and Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA2B INTERFERON; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CORTICOSTEROID; COTRIMOXAZOLE; F ACTIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; LIVER ENZYME; PEGINTERFERON; PREDNISONE; RIBAVIRIN; VIRUS RNA;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADD ON THERAPY; ADULT; AFRICAN AMERICAN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC PROPHYLAXIS; ANTIVIRAL THERAPY; ARM WEAKNESS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BURKITT LYMPHOMA; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; HYPERGLYCEMIA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; LIVER BIOPSY; LIVER CIRRHOSIS; LOW DRUG DOSE; MALE; MIXED INFECTION; PATIENT REFERRAL; PNEUMOCYSTIS PNEUMONIA; PSEUDOMONAS PNEUMONIA; PYELONEPHRITIS; REBOUND; REMISSION; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; RETINA DETACHMENT; SEPSIS; SEROLOGY; STEATOSIS; TREATMENT DURATION; VIREMIA; VIROLOGY; VISUAL DISORDER;

ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HEPATITIS, AUTOIMMUNE; HIV INFECTIONS; HUMANS; INTERFERONS; LIVER FAILURE, ACUTE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RIBAVIRIN; TREATMENT OUTCOME;

EID: 67651154288     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2008.0149     Document Type: Article

References (19)

1. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354: 54-66.
2. Puius YA, Dove LM, Brust DG, Shah DP, Lefkowitch JH. Three cases of autoimmune hepatitis in HIV-infected patients. J Clin Gastroenterol 2008; 42: 425-429.
3. Resti M, de Martino M, Tucci F, et al. Infant's HIV-1-related liver disease miming autoimmune hepatitis. VII International Conference of AIDS. Rome, Italy: 1991.
4. German V, Vassiloyanakopoulos A, Sampaziotis D, Giannakos G. Autoimmune hepatitis in an HIV infected patient that responded to antiretroviral therapy. Scand J Infect Dis 2005; 37: 148-151.
5. Ramadori G, Lohr H, Rossol S, Manns M, Meyer zum Buschenfelde KH. Human immunodeficiency virus infection mimics autoimmune hepatitis-A case report. Klin Wochenschr 1988; 66: 1040.
6. Cazanave C, Rakotondravelo S, Morlat P, et al. [Autoimmune hepatitis in a HIV-HCV co-infected patient: Diagnostic and therapeutic difficulties]. Rev Med Interne 2006; 27: 414-419.
7. Coriat R, Podevin P. Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient. Int J STD AIDS 2008; 19: 208-210.
8. Vento S, Di Perri G, Garofano T, et al. Hazards of interferon therapy for HBV-seronegative chronic hepatitis. Lancet 1989; 2: 926.
9. Kogure T, Ueno Y, Fukushima K, et al. Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment. World J Gastroenterol 2007; 13: 4394-4397.
10. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
11. De Milito A, Nilsson A, Titanji K, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004; 103: 2180- 2186.
12. Frenzel C, Herkel J, Luth S, et al. Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis. Am J Gastroenterol 2006; 101: 2731-2736.
13. Jaskowski TD, Konnick EQ, Ashwood ER, Litwin CM, Hill HR. Prevalence of IgG autoantibody against F-actin in patients suspected of having autoimmune or acute viral hepatitis. J Clin Lab Anal 2007; 21: 249-253.
14. Cholongitas E, Samonakis D, Patch D, et al. Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus. Transplantation 2006; 81: 488-490.
15. Kontorinis N, Agarwal K, Elhajj N, Fiel MI, Schiano TD. Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transpl 2006; 12: 827-830.
16. Talal AH, Ribeiro RM, Powers KA, et al. Pharmacodynamics of PEG-IFN alpha differentiate HIV/HCV coinfected sustained virological responders from nonresponders. Hepatology 2006; 43: 943-953.
17. Sherman KE, Shire NJ, Rouster SD, et al. Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virusinfected patients. Gastroenterology 2005; 128: 313-327.
18. Vergani D, Mieli-Vergani G. Autoimmune hepatitis. Autoimmun Rev 2003; 2: 241-247.
19. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 29, 2008: 1-128. www.aidsinfo .nih.gov/ContentFiles/AdultandAdolescentGL.pdf (Last accessed June 26, 2008).